Skip to main content

Table 5 Proportion of treatment-associated adverse events stratified by type and time

From: Efficacy and safety of praziquantel treatment against Schistosoma mansoni infection among pre-school age children in southern Ethiopia

Type of AEs

N

Day1 at 4 h [N (%)]

Day2 at 24 h [N (%)]

Day 8 at 192 h [N (%)]

Stomachache

27

19 (70.4)

8 (29.6)

 

Diarrhea

19

10 (52.6)

7 (36.8)

2 (10.5)

Nausea

18

12 (66.7)

4 (22.2)

2 (11.1)

Drowsiness

17

9 (52.9)

8 (47.1)

 

Vomiting

16

10 (62.5)

4 (25.0)

2 (12.5)

Dizziness

15

11 (73.3)

4 (26.7)

 

Fever

17

12 (70.6)

5 (29.4)

 

Loss of appetite

14

9 (64.3)

5 (35.7)

 

Headache

13

8 (61.5)

5 (38.5)

 

Cough

3

2 (66.7)

1 (33.3)

 

Confusion

5

5 (100.0)

  

Itching

3

2 (66.7)

 

1 (33.3)

Other symptoms

2

1 (50.0)

1 (50.0)

 

Total

169

110 (65.1)

52 (30.8)

7 (4.1)

  1. AEs: adverse events; N: total number of AEs; h: hours